Lobe Sciences Past Earnings Performance

Past criteria checks 0/6

Lobe Sciences's earnings have been declining at an average annual rate of -6.8%, while the Pharmaceuticals industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 27.4% per year.

Key information

-6.8%

Earnings growth rate

13.9%

EPS growth rate

Pharmaceuticals Industry Growth7.3%
Revenue growth rate27.4%
Return on equityn/a
Net Margin-303.7%
Last Earnings Update31 May 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Lobe Sciences makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:6YX0 Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 May 241-321
29 Feb 241-331
30 Nov 231-331
31 Aug 231-531
31 May 230-630
28 Feb 230-831
30 Nov 220-1040
31 Aug 220-1240
31 May 220-2241
28 Feb 220-2741
30 Nov 210-2652
31 Aug 210-2351
31 May 210-1251
28 Feb 210-651
30 Nov 200-440
31 Aug 200-440
31 May 200-330
29 Feb 200-240
30 Nov 191-130
31 Aug 191-130
31 Aug 181-1130

Quality Earnings: 6YX0 is currently unprofitable.

Growing Profit Margin: 6YX0 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 6YX0 is unprofitable, and losses have increased over the past 5 years at a rate of 6.8% per year.

Accelerating Growth: Unable to compare 6YX0's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 6YX0 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (25.4%).


Return on Equity

High ROE: 6YX0's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 00:58
End of Day Share Price 2024/12/23 00:00
Earnings2024/05/31
Annual Earnings2023/08/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lobe Sciences Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ishan MajumdarBaptista Research